NYSE - Nasdaq Real Time Price USD

The Cigna Group (CI)

352.28 -0.37 (-0.10%)
At close: 4:00 PM EDT
350.00 -2.28 (-0.65%)
After hours: 6:01 PM EDT
Loading Chart for CI
DELL
  • Previous Close 352.65
  • Open 351.04
  • Bid 346.17 x 1100
  • Ask 355.29 x 1000
  • Day's Range 350.06 - 353.99
  • 52 Week Range 240.50 - 365.71
  • Volume 1,120,749
  • Avg. Volume 1,566,214
  • Market Cap (intraday) 99.923B
  • Beta (5Y Monthly) 0.58
  • PE Ratio (TTM) 20.26
  • EPS (TTM) 17.39
  • Earnings Date May 2, 2024
  • Forward Dividend & Yield 5.60 (1.59%)
  • Ex-Dividend Date Mar 5, 2024
  • 1y Target Est 383.14

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.

www.cigna.com

70,325

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CI

Performance Overview: CI

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CI
18.13%
S&P 500
6.33%

1-Year Return

CI
42.27%
S&P 500
22.70%

3-Year Return

CI
47.41%
S&P 500
21.33%

5-Year Return

CI
142.39%
S&P 500
72.88%

Compare To: CI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CI

Valuation Measures

Annual
As of 4/23/2024
  • Market Cap

    100.03B

  • Enterprise Value

    123.14B

  • Trailing P/E

    20.28

  • Forward P/E

    12.41

  • PEG Ratio (5yr expected)

    0.90

  • Price/Sales (ttm)

    0.54

  • Price/Book (mrq)

    2.16

  • Enterprise Value/Revenue

    0.63

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.65%

  • Return on Assets (ttm)

    3.75%

  • Return on Equity (ttm)

    11.79%

  • Revenue (ttm)

    195.19B

  • Net Income Avi to Common (ttm)

    5.16B

  • Diluted EPS (ttm)

    17.39

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    8.75B

  • Total Debt/Equity (mrq)

    68.80%

  • Levered Free Cash Flow (ttm)

    8.25B

Research Analysis: CI

Analyst Price Targets

348.00
383.14 Average
352.28 Current
420.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: CI

Fair Value

352.28 Current
 

Dividend Score

0 Low
CI
Sector Avg.
100 High
 

Hiring Score

0 Low
CI
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
CI
Sector Avg.
100 High
 

Research Reports: CI

  • CI: Lowering target price to $364.00

    THE CIGNA GROUP has an Investment Rating of HOLD; a target price of $364.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • CI: Lowering target price to $375.00

    THE CIGNA GROUP has an Investment Rating of HOLD; a target price of $375.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • CI: Raising target price to $381.00

    THE CIGNA GROUP has an Investment Rating of HOLD; a target price of $381.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • Analyst Report: The Cigna Group

    Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense, and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, and the company operates mostly in the US with 18 million US medical members covered as of December 2023.

    Rating
    Price Target
     

People Also Watch